Chapter 39Mass Production of Full-Length IgG Monoclonal Antibodies from Mammalian, Yeast, and Bacterial Hosts
Sang T. Jung and Dong-Il Kim
IgG antibodies are tetramers formed by the assembly of two identical heavy chains and two light chains and are critical modulators of various immune responses (Figure 39.1). Since 1975 when Georges Köhler and Cesar Milstein developed hybridoma technology, mAbs have been utilized extensively for therapeutic and diagnostic applications. Due to many advantages over conventional chemically synthesized drugs, in particular, in terms of target specificity and serum half-lives, mAbs have been considered one of the most potent and effective biopharmaceutics used to treat cancer, infectious diseases, inflammation, ...
Get Emerging Areas in Bioengineering now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
